Understanding Drugs Markets

Drawing on anthropology, historical sociology and social-epidemiology, this multidisciplinary book investigates how pharmaceuticals are produced, distributed, prescribed, (and) consumed, and regulated in order to construct a comprehensive understanding of the issues that drive (medicine) pharmaceutical markets in the Global South today. Based on primary research conducted in Benin and Ghana, and additional data collected in Cambodia and the Ivory Coast, this volume uses artemisinin-based combination therapies (ACTs) against malaria as a central case study. It highlights the influence of the countries colonial and post-colonial history on their models for state regulation, production, and distribution, explores the determining role transnational actors as well as industries from the North but also and increasingly from the South play in influencing local pharmaceutical markets and looks at the behaviour of health care professionals and individuals. Stepping back, the authors then unpick the pharmaceuticalization process and the multiple regulations at stake by looking at the workings of, and linkages between, (biomedical health) pharmaceutical systems, (representatives of companies) industries, actors in private distribution, and consumer practices. Providing a thorough comparative analysis of the advantages and disadvantages of different pharmaceutical systems, it is an important contribution to the literature on pharmaceutalization and the governance of medication. It is of interest to students, researchers and policy-makers interested in medical anthropology, the sociology of health and illness, global health, healthcare management and pharmacy.

This book examines the drug dealer in contemporary society from an interdisciplinary perspective and considers the increasingly blurred demarcation between illegitimate and legitimate drug markets. It explores the motives and drivers of those involved in drug supply and dispels common and stereotypical myths and misconceptions surrounding illegal drug markets and those who operate within them. The drug dealer has become one of our foremost contemporary ‘folk devils’. Those who trade in substances prohibited by law are the subject of array of inaccurate myths and urban legends. Criminology has tended either to shoehorn drug dealers into neat typologies or portray them as ‘victims’ of an uncaring, predatory post-modern society. In reality, we know relatively little about the complex and diverse world of drug markets and our concentration inevitably falls on low-end ‘retail’ dealers who operate in the most visible sectors of the illegal economy. Bringing together an international group of experts, this book considers perspectives from around the world, including UK, USA, South America, Spain, India and Australia. This book will be of interest to students and researchers across criminology, law, sociology, criminal justice and public health, and will be essential reading for those taking courses on drugs, drug markets and substance misuse.

Despite efforts to reduce drug consumption in the United States over the past 35 years, drugs are just as cheap and available as they have ever been. Cocaine, heroin, and methamphetamines continue to cause great harm in the country, particularly in minority communities in the major cities. Marijuana use remains a part of adolescent development for about half of the country's young people, although there is controversy about the extent of its harm. Given the persistence of drug demand in the face of lengthy and expensive efforts to control the markets, the National Institute of Justice asked the National Research Council to undertake a study of current research on the demand for drugs in order to help better focus national efforts to reduce that demand. This study complements the 2003 book, Informing America's Policy on Illegal Drugs by giving more attention to the sources of demand and assessing the potential of demand-side interventions to make a substantial difference to the nation's drug problems. Understanding the Demand for Illegal Drugs therefore focuses tightly on demand models in the field of economics and evaluates the data needs for advancing this relatively undeveloped area of investigation.

Drawing on anthropology, historical sociology and social-epidemiology, this multidisciplinary book investigates how pharmaceuticals are produced, distributed, prescribed, (and) consumed, and regulated in order to construct a comprehensive understanding of the issues that drive (medicine) pharmaceutical markets in the Global South today. Based on primary research conducted in Benin and Ghana, and additional data collected in Cambodia and the Ivory Coast, this volume uses artemisinin-based combination therapies (ACTs) against malaria as a central case study. It highlights the influence of the countries colonial and post-colonial history on their models for state regulation, production, and distribution, explores the determining role transnational actors as well as industries from the North but also and increasingly from the South play in influencing local pharmaceutical markets and looks at the behaviour of health care professionals and individuals. Stepping back, the authors then unpick the pharmaceuticalization process and the multiple regulations at stake by looking at the workings of, and linkages between, (biomedical health) pharmaceutical systems, (representatives of companies) industries, actors in private distribution, and consumer practices. Providing a thorough comparative analysis of the advantages and disadvantages of different pharmaceutical systems, it is an important contribution to the literature on pharmaceutalization and the governance of medication. It is of interest to students, researchers and policy-makers interested in medical anthropology, the sociology of health and illness, global health, healthcare management and pharmacy. The Open Access version of this book, available at http://www.taylorfrancis.com/books/9780429329517, has been made available under a Creative Commons Attribution-Non Commercial-No Derivatives 4.0 license.

How do local drug markets impact on their 'host' communities? This report, based on the largest British study of drug-dealing to date, draws on work in three areas where drug dealing is prevalent, and assesses the the financial, social, environmental and cultural impact of local drug markets on the communities in which they operate. It documents the views of community members about the market and its impact, whilst exploring the career paths and motivations that lead people into drug dealing, together with the social and demographic differences between dealers, users and others in the community. The authors consider the extent to which drug dealers are predatory outsiders who 'prey on' the local community, suggesting that local drug markets are often integrated - to greater or lesser extent - in the licit and illicit economies of deprived areas. Understanding drug selling in communities highlights the complex nature of drug dealing and its effect on local communities. It outlines a range of possible enforcement measures and will be of interest to a range of practitioners concerned with communities, drug prevention and rehabilitation as well as local authorities, the police and probation service.

This authoritative and comprehensive book makes the reader familiar with the processes of bringing orphan drugs to the global market. There are between 5,000 and 7,000 rare diseases and the number of patients suffering from them is estimated to be more than 50 million in the US and Europe. Before the orphan drug legislation enacted in the US in 1983, there was a limited interest from industry to develop treatment for very small patient groups. One of the difficulties is, of course, that similar levels of investment are needed from a pharmaceutical company to bring a drug to the market for both small and large patient groups.The journey from application of an orphan drug designation to a reimbursed market- approved drug is long and many obstacles occur during the journey.After reading the book, readers will: Understand who the players/stakeholders are in the rare orphan disease field and their specific needs and concerns: patients and patient organizations, researchers and treating physicians within the field, industry, regulatory and reimbursement bodies* Understand the strong partnership between the different players and the various initiatives to improve and increase access to treatment for patients; minimizing the gap between numbers of known diseases, orphan designations, approved drugs and paid drugs.The book also provides short practical case stories from patients and researchers, as well as representatives from industry and authorities on the challenges they came across in developing orphan drugs or getting access to orphan drugs. A comprehensive overview of strategy, key activities and considerations of how to bring an orphan drug from concept to the market and make it available to patients A source of updated information, news and trends for those who are already active in this fast-evolving field Covers the global definitions and the criteria for getting an orphan drug designation in, for example, the US and Europe

"Bennett and Holloway's Understanding Drugs, Alcohol, and Crime isthe best, most up-to-date and comprehensive examination for theUnited Kingdom of interactions among drugs, alcohol, and crime. Theauthors exhaustively and authoritatively survey current knowledge inthe UK, and from many other countries, on drug and alcohol use ascause, and consequence, of crime, and the effects of law enforcementand treatment responses. Clearly written, unfailingly lucid, andadmirably accurate, this book will be the indispensable work onBritish drug policy for many years to come." Professor Michael Tonry, University of Minnesota Law School, USA "What makes this book particularly interesting is the refreshingly non judgmental presentation which conveys the essence of very important issues in contemporary society. Therefore, this is an ideal text not only for students but also for policy makers, drugs and alcohol counsellors, treatment agencies and everyone interested in doing research on drugs, alcohol and crime." Nicoletta Policek, University of Abertay, Dundee "The publication is not only an excellent summary of the existing research in Great Britain, and to a lesser extent from other jurisdictions, it is a foundation for future research by evoking , and at times provoking, questions and offering a variety of possible responses." Hirsch Greenberg, University of Regina What is the connection between drugs, alcohol and crime? What works in reducing drugs and alcohol-related crime? The book provides a succinct overview of current theory and research on the links between drugs, alcohol use and crime. It discusses the legal and social context of drug and alcohol use and identifies current levels of consumption. Focusing on the UK context, it also takes into account international research where appropriate. Detailed review of the research literature on the connections between drug use and crime Examines the current government anti-drugs policy and assesses the effectiveness of programmes that have been used to reduce drug and alcohol-related crime. The book concludes that future government drugs policy should pay particular attention to the lessons learned from research on the connection between drug and alcohol use and crime. Ideal for criminology, criminal justice, social policy and social work students, this book will also be a useful source of information for policy makers, the police, probation workers, social workers, drugs and alcohol counsellors, treatment agencies, sentencers, voluntary agencies, Drug Action Teams, and others with an interest in research on drugs and crime.

This monograph is the product of the decision of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) to launch a project in 1996 to obtain a comprehensive overview of qualitative research on drugs in Europe. The opening section highlights the multiple roles of qualitative research in understanding and responding to drug use. Part II addresses the impact of qualitative research on policy-making. Part III provides examples of research conducted in European Union cities that has been specifically designed to identify and verify new trends in drug use. Part IV on risk behaviour demonstrates how qualitative research methods have made a considerable contribution to the knowledge and understanding of health risks associated with drug injecting. Subsequent sections consider the theme of social exclusion, drug markets, and drug services evaluation. The final section is given over to qualitative research on drug use within a global research agenda. It reveals the scale of qualitative drug research varies greatly between countries, that little is published in the drug-specific scientific journals and that high quality work often appears to fail to influence policy. The monograph concludes that a comprehensive approach should include the training of individual experts and research teams and exchanges of experience between researchers across and beyond Europe.